Sabir M, Wolfe L, Adams D, Ciccone C, Porter F, Gahl W
Rare. 2025; 3.
PMID: 39991440
PMC: 11845233.
DOI: 10.1016/j.rare.2025.100065.
Zhang H, Liu X, Li B, Zhang Y, Gao H, Zhao X
Front Cell Dev Biol. 2023; 11:1180483.
PMID: 37564375
PMC: 10411196.
DOI: 10.3389/fcell.2023.1180483.
Singh K, Quinville B, Mitchell M, Chen Z, Walia J
Genes (Basel). 2022; 13(11).
PMID: 36360256
PMC: 9690576.
DOI: 10.3390/genes13112020.
Detzner J, Pohlentz G, Muthing J
Int J Mol Sci. 2022; 23(13).
PMID: 35805890
PMC: 9266556.
DOI: 10.3390/ijms23136884.
Engel L, Alves J, Hennek J, Goueli S, Zegzouti H
Molecules. 2021; 26(20).
PMID: 34684811
PMC: 8539010.
DOI: 10.3390/molecules26206230.
Chitotriosidase as a biomarker for gangliosidoses.
Kim S, Whitley C, Jarnes J
Mol Genet Metab Rep. 2021; 29:100803.
PMID: 34646735
PMC: 8498089.
DOI: 10.1016/j.ymgmr.2021.100803.
GM1 Gangliosidosis-A Mini-Review.
Nicoli E, Annunziata I, dAzzo A, Platt F, Tifft C, Stepien K
Front Genet. 2021; 12:734878.
PMID: 34539759
PMC: 8446533.
DOI: 10.3389/fgene.2021.734878.
Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
Blaho V
Adv Exp Med Biol. 2020; 1274:101-135.
PMID: 32894509
DOI: 10.1007/978-3-030-50621-6_6.
Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience.
Fischetto R, Palladino V, Mancardi M, Giacomini T, Palladino S, Gaeta A
Mol Genet Genomic Med. 2020; 8(10):e1371.
PMID: 32779865
PMC: 7549581.
DOI: 10.1002/mgg3.1371.
Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.
Chen Y, Jian J, Hettinghouse A, Zhao X, Setchell K, Sun Y
J Mol Med (Berl). 2018; 96(12):1359-1373.
PMID: 30341570
PMC: 6240367.
DOI: 10.1007/s00109-018-1703-0.
TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward.
Guilarte T
Pharmacol Ther. 2018; 194:44-58.
PMID: 30189290
PMC: 6348013.
DOI: 10.1016/j.pharmthera.2018.09.003.
Pathobiology of Christianson syndrome: Linking disrupted endosomal-lysosomal function with intellectual disability and sensory impairments.
Kerner-Rossi M, Gulinello M, Walkley S, Dobrenis K
Neurobiol Learn Mem. 2018; 165:106867.
PMID: 29772390
PMC: 6235725.
DOI: 10.1016/j.nlm.2018.05.004.
Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises.
Mohamed F, Al-Gazali L, Al-Jasmi F, Ali B
Front Pharmacol. 2017; 8:448.
PMID: 28736525
PMC: 5500627.
DOI: 10.3389/fphar.2017.00448.
The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression.
Deodato F, Procopio E, Rampazzo A, Taurisano R, Donati M, Dionisi-Vici C
Metab Brain Dis. 2017; 32(5):1529-1536.
PMID: 28577204
DOI: 10.1007/s11011-017-0044-y.
Infantile gangliosidoses: Mapping a timeline of clinical changes.
Jarnes Utz J, Kim S, King K, Ziegler R, Schema L, Redtree E
Mol Genet Metab. 2017; 121(2):170-179.
PMID: 28476546
PMC: 5727905.
DOI: 10.1016/j.ymgme.2017.04.011.
TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology.
Loth M, Choi J, McGlothan J, Pletnikov M, Pomper M, Guilarte T
Neurobiol Dis. 2015; 85:174-186.
PMID: 26545928
PMC: 4688219.
DOI: 10.1016/j.nbd.2015.11.001.
Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathy.
Kano S, Yuan M, Cardarelli R, Maegawa G, Higurashi N, Gaval-Cruz M
Curr Mol Med. 2015; 15(2):138-45.
PMID: 25732146
PMC: 4428755.
DOI: 10.2174/1566524015666150303110300.
Synthesis of an Aminooxy Derivative of the Trisaccharide Globotriose Gb3.
Ghosh S, Andreana P
J Carbohydr Chem. 2014; 33(7-8):381-394.
PMID: 25382930
PMC: 4219983.
DOI: 10.1080/07328303.2014.925913.
Sorting out the trash: the spatial nature of eukaryotic protein quality control.
Sontag E, Vonk W, Frydman J
Curr Opin Cell Biol. 2014; 26:139-146.
PMID: 24463332
PMC: 4204729.
DOI: 10.1016/j.ceb.2013.12.006.
Ethylenedioxy-PIP2 oxalate reduces ganglioside storage in juvenile Sandhoff disease mice.
Arthur J, Wilson M, Larsen S, Rockwell H, Shayman J, Seyfried T
Neurochem Res. 2013; 38(4):866-75.
PMID: 23417430
PMC: 6554746.
DOI: 10.1007/s11064-013-0992-5.